“ERRATUM: Systematic Review and Meta-Analysis of the Efficacy and Safety of Amfepramone and Mazindol As a Monotherapy for the Treatment of Obese or Overweight Patients”. Clinics, vol. 73, Jan. 2018, p. e1err, https://doi.org/10.6061/clinics/2018/e1err.